Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

REASSURE-NIRS Registry

RESSURE-NIRS registry is designed to investigate clinical and pathophysiological characteristics of NIRS-derived lipid-rich plaque in patients with coronary artery disease. This is an on-going multi-center prospective registry in Japan.

Participants needed: 2,000
Trial details
Age: 20-95Biological sex: AllType: ObservationalSponsor: National Cerebral and Cardiovascular Center, JapanUpdated: Aug 15, 2025Locations: 2Duration: 5 Years
Eligibility criteria

Not listed

Status: Recruiting

Japanese Catheter Ablation Registry

Japanese Cather Ablation (J-AB) Registry is a voluntary nationwide registry, performed by Japanese Heart Rhythm Society, collaborated with the National Cerebral and Cardiovascular Center. The objectives of this registry are to observe and describe developments in the catheter ablation treatment of arrhythmia in Japan and to provide reliable information on the type of activity performed and the facilities available in Japanese arrhythmia units.

Participants needed: 400,000
Trial details
Biological sex: AllType: ObservationalSponsor: National Cerebral and Cardiovascular Center, JapanUpdated: Nov 13, 2023Locations: 1
Eligibility criteria

Patients treated with catheter ablation in Japan

Patients who refused to consent

Status: Recruiting

Japanese Lead Extraction Registry

Japanese Lead Extraction (J-LEX) Registry is an observational nationwide registry, performed by Japanese Heart Rhythm Society, collaborated with the National Cerebral and Cardiovascular Center. The acute success rate at discharge and the complications associated with transvenous lead extraction will be collected. J-LEX registry will provide a reliable information on indications, methods, the success rate, complications and the prognosis at 30 days prognosis.

Participants needed: 5,000
Trial details
Biological sex: AllType: ObservationalSponsor: National Cerebral and Cardiovascular Center, JapanUpdated: Nov 13, 2023Locations: 1Duration: 30 Days
Eligibility criteria

Patients undergoing transvenous lead extraction in Japan.

Patients who receive open-chest surgical extraction alone. [+1]